Clinical Evaluation of Safety and Efficacy of Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

July 25, 2022

Study Completion Date

July 25, 2022

Conditions
Improvement of Dry Eye Disease
Interventions
DEVICE

Forma Eye Applicator

"Eligible subjects will receive up to 3 treatments (2-3 weeks interval) with the Forma Eye Applicator according to the study protocol.~The subject will return for 3 follow up visits: four weeks (4wk FU), 12 weeks (12wk FU), twenty-four weeks (24wk FU) after the last treatment."

Trial Locations (3)

78745

Sean Paul, Austin

80016

Centennial Eye Associates, Aurora

03801

Excellent Vision, Portsmouth

All Listed Sponsors
lead

InMode MD Ltd.

INDUSTRY

NCT04120584 - Clinical Evaluation of Safety and Efficacy of Radio Frequency (Forma Eye) Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter